Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Concert Pharmaceutic (CNCE)

Concert Pharmaceutic (CNCE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 160,174
  • Shares Outstanding, K 23,800
  • Annual Sales, $ 10,510 K
  • Annual Income, $ -56,020 K
  • 60-Month Beta 0.88
  • Price/Sales 14.50
  • Price/Cash Flow N/A
  • Price/Book 1.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.89
  • Number of Estimates 4
  • High Estimate -0.82
  • Low Estimate -1.04
  • Prior Year -0.89
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.76 +20.49%
on 10/15/19
7.11 -2.39%
on 11/08/19
+1.06 (+18.03%)
since 10/11/19
3-Month
5.36 +29.48%
on 10/01/19
12.69 -45.31%
on 09/05/19
-3.32 (-32.36%)
since 08/09/19
52-Week
5.36 +29.48%
on 10/01/19
17.83 -61.08%
on 03/21/19
-9.12 (-56.79%)
since 11/09/18

Most Recent Stories

More News
Concert Pharmace Has Returned 15.8% Since SmarTrend Recommendation (CNCE)

SmarTrend identified a Downtrend for Concert Pharmace (NASDAQ:CNCE) on September 27th, 2019 at $7.93. In approximately 1 month, Concert Pharmace has returned 15.84% as of today's recent price of $6.67....

CNCE : 6.94 (+3.12%)
Concert Pharmaceuticals (CNCE) Reports Q3 Loss, Misses Revenue Estimates

Concert (CNCE) delivered earnings and revenue surprises of 15.29% and -97.14%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

CNCE : 6.94 (+3.12%)
Concert: 3Q Earnings Snapshot

LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Thursday reported a loss of $17.2 million in its third quarter.

CNCE : 6.94 (+3.12%)
Concert Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Company Update

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the third quarter of 2019.

CNCE : 6.94 (+3.12%)
Concert Pharmaceuticals to Host KOL Webcast Event Focused on CTP-692 and Schizophrenia

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will host a conference call and webcast event with a key opinion leader in the field of psychiatry and schizophrenia on Thursday, November...

CNCE : 6.94 (+3.12%)
Analysts Estimate Concert Pharmaceuticals (CNCE) to Report a Decline in Earnings: What to Look Out for

Concert (CNCE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CNCE : 6.94 (+3.12%)
Concert Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 7, 2019

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its third quarter 2019 financial results on Thursday, November 7, 2019, before the U.S. financial markets open. The Company...

CNCE : 6.94 (+3.12%)
Shares of CNCE Down 21.6% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Concert Pharmace (NASDAQ:CNCE) on September 27th, 2019 at $7.93. In approximately 3 weeks, Concert Pharmace has returned 21.64% as of today's recent price of $6.21....

CNCE : 6.94 (+3.12%)
Concert Pharmaceuticals Presents Positive Phase 2 Data in Alopecia Areata During Late-Breaker Session at EADV Congress

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today presented results from its recently completed Phase 2 dose-ranging trial of the investigational medicine CTP-543 in patients with moderate-to-severe alopecia...

CNCE : 6.94 (+3.12%)
Concert Pharmaceuticals to Provide Overview of Clinical Pipeline at Cantor Healthcare Conference

--Webcast details for Cantor Healthcare Conference presentation Thursday, October 3, 2019 at 5:20 p.m. ET

CNCE : 6.94 (+3.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade CNCE with:

Business Summary

Concert Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on applying its DCE Platform (R) to create novel small molecule drugs. The Company manufactures drugs in various therapeutic areas such as hot flashes, HIV, renal hepatic, neuropathic pain, MRSA infection, and schizophrenia, multiple...

See More

Key Turning Points

2nd Resistance Point 7.27
1st Resistance Point 7.11
Last Price 6.94
1st Support Level 6.67
2nd Support Level 6.39

See More

52-Week High 17.83
Fibonacci 61.8% 13.07
Fibonacci 50% 11.60
Fibonacci 38.2% 10.12
Last Price 6.94
52-Week Low 5.36

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar